RedHill Biopharma Ltd.

RDHL·NasdaqCM·Healthcare
Compare
0.4220+0.0061 (+1.47%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market0.4407+0.0187 (+4.43%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.4159
Open0.3950
Day range0.39500.4220
52-week range0.38001.6000
Off day high0.00%
Off 52-week high−73.63%
Volume39.10K
Avg. volume (3M)2.08M
Market cap3.75M
EPS (TTM)0.000000
Forward P/E14.07
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)4.87
Shares outstanding8.89M
Short interest1.46% of float
Earnings dateApr 10, 2025
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
RDHL COLINZ.BO CPIX GUD.TO 2M7C.F 4547.T
Market cap 3.75M 173.79M 66.52M 1.11B 2.87B 161.53B
P/E (TTM) — 6.2 — 75.3 14.8 14.4
Forward P/E 14.1 — 31.7 43.5 — 17.6
Price/book 0.5 1.7 3.8 1.4 1.2 0.7
Dividend yield — — — — 3.42% 3.46%
1-year change −63.62% +73.32% +102.74% +86.16% −24.84% −6.36%
Today +1.47% −0.01% +3.02% +0.36% +2.61% +3.06%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.

Latest news

All RDHL news ›
themarketsdaily.com·Negative

One moment, please...

Roblox (NYSE:RBLX – Get Free Report) had its price objective dropped by equities researchers at Jefferies Financial Group from $38.00 to $35.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently…

Stock Titan·Positive

RedHill Biopharma raises at-the-market offering cap

Qualcomm Statement on Trial Verdict Win This report is incorporated by reference into RedHill Biopharma's Form S-8 and Form F-3 registration statements. Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities…

@StockTitan_net·

RedHill Biopharma gets 180-day Nasdaq extension

RedHill Biopharma Ltd. received Nasdaq’s notice on October 6, 2026, granting an additional 180 calendar days, through April 5, 2027, to regain compliance with the $1.00 per-share minimum bid-price requirement. RedHill Biopharma Ltd.…

@StockTitan_net·

RedHill Biopharma COO acquires 27.6M depositary shares

RedHill Biopharma (RDHL) is a Nasdaq-listed specialty biopharmaceutical company focused on U.S. development and commercialization of GI, infectious disease and oncology drugs. - [Form 4] RedHill Biopharma Ltd. Insider Trading Activity…

From the 4Search news index, newest first.

In the news

8mentions in 30 days
4with it in the headline
Negativesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 8 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance